附註:Accompanying CD-ROM in back pocket contains background papers in Microsoft Word format and code for the epidemic models used in the book.
Includes bibliographical references and index.
Foreword -- Acknowledgments -- Executive Summary -- List of Acronyms and Abbreviations -- 1. Introduction -- Antiretroviral Therapy -- Scope of the Report -- 2. India's HIV/AIDS Epidemic -- The Epidemiology of HIV in India -- Responses to the Epidemic -- 3. HIV/AIDS and Antiretroviral Therapy -- Treating Opportunistic Illnesses with or without Antiretroviral Therapy -- Toxicity, Adherence, and the Development of Resistance as a Result of Antiretroviral Drug Therapy -- Monitoring the Progress of HIV/AIDS Disease and the Efficacy of Antiretroviral Therapy.
Biological and Behavioral Effects of Antiretroviral Therapy on Transmission -- 4. Projecting the Course of India's HIV/AIDS Epidemic without Policy Change -- A Framework for Analyzing Antiretroviral Therapy Policy -- Structure of the Epidemiological Projection Model -- 5. Evaluating the Costs and Consequences of Alternative Government Policies -- Comparison of Policy Options Assuming Antiretroviral Therapy Has No Effect on Risk Behavior -- Comparison of Baseline and Below the Poverty Line Policy Assuming Antiretroviral Therapy Affects Risk Behavior.
Cost-Effectiveness of Alternative Antiretroviral Therapy Policies -- 6. Recommendations and Conclusions -- Index -- List of Boxes -- 1-1 Is Government Financing of AIDS Treatment in Poor Countries Ethical? -- 2-1 Sources, Limitations, and Assumptions behind Current Estimates of HIV Incidence and Prevalence in India, 2002 -- 3-1 WHO Guidelines on First- and Second-Line Antiretroviral Therapy -- 4-1 Performance-Based Fiscal Mechanisms in India -- 4-2 International Experience with Government-Financed Antiretroviral Therapy -- List of Tables.
2-1 Estimated Number of People with HIV/AIDS, by State, 2002 -- 2-2 Estimated Number of People with AIDS in 60 Indian Cities, 2002 -- 2-3 Financing of India 's National HIV/AIDS Control Program, circa 2002 -- 2-4 Financing of Curative Health Services in India -- 2-5 Prices of Patented Drugs in India and Selected Other Countries, Mid-1990s -- 3-1 Minimum Risk of Contracting HIV through Sexual Contact, Mother-to-Child Transmission, and Blood or Blood Products -- 3-2 Life Expectancy from Structured and Unstructured Antiretroviral Therapy.
3-3 Possible Beneficial and Adverse Effects of Antiretroviral Therapy on HIV Transmission -- 4-1 Cost and Timing of Treating Opportunistic Illnesses of Average Indian with HIV under Different Antiretroviral Treatment Regimes (circa 2002) -- 4-2 Opportunity Cost of Antiretroviral Therapy in Terms of Forgone HIV/AIDS Prevention -- 5-1 Projected Impact of ADHERE Policy in India, 1998-2033 -- 5-2 Projected Impact of MTCT+ Policy in India, 1998-2033 -- 5-3 Projected Impact of Below the Poverty Line Policy in India, 1998-2033 -- List of Figures.
摘要:This title projects the future implications of three alternative AIDS treatment financing policies for the health burden of AIDS in India and for its overall health expenditures. Written by an interdisciplinary team of AIDS experts, the book presents new data on the supply and demand for antiretroviral treatment in India and new models of the epidemiological effects and the financial costs of alternative policies.
